Macrophage Marker Market Report 2026
Global Outlook – By Marker Type (Cluster of Differentiation 68, Cluster of Differentiation 163, Cluster of Differentiation 206, Cluster of Differentiation 14, Cluster of Differentiation 11b, Cluster of Differentiation 64, Cluster of Differentiation 11c), By Macrophage Phenotype (M1 Macrophage Markers, M2 Macrophage Markers), By Disease Area (Oncology And Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, Other Disease Areas), By Application (Research Use, Diagnostic Use And Drug Development), By End User (Research Institutes And Academic Centers, Pharmaceutical And Biotechnology Companies, Clinical And Diagnostic Laboratories, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Macrophage Marker Market Overview
• Macrophage Marker market size has reached to $0.52 billion in 2025 • Expected to grow to $0.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.3% • Growth Driver: Rising Cancer Cases Are Fueling The Growth Of The Market Due To Increasing Demand For Tumor-Associated Macrophage Profiling And Biomarker Discovery • Market Trend: Macrophage Marker Antibody Development Expands Research Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Macrophage Marker Market?
The macrophage markers are biomolecules that enable the identification and characterization of macrophages based on their presence, activation state, and biological functions within tissues or cell populations. They help distinguish different macrophage populations and provide insights into immune responses, inflammation, and tissue homeostasis. Macrophage markers are widely utilized to study macrophage behavior, distribution, and interactions in both normal physiological and disease-related conditions. The main marker types of macrophage markers include cluster of differentiation 68, cluster of differentiation 163, cluster of differentiation 206, cluster of differentiation 14, cluster of differentiation 11b, cluster of differentiation 64, and cluster of differentiation 11c. Cluster of differentiation 68 refers to a glycoprotein commonly expressed by macrophages and used as a cellular marker for identifying and characterizing macrophage populations in biological research and disease studies. These markers are associated with M1 macrophage markers and M2 macrophage markers and are studied across disease areas including oncology and infectious diseases, autoimmune diseases, cardiovascular diseases, neurological disorders, and other disease areas. The key applications include research use, diagnostic use, and drug development, while the end-users include research institutes and academic centers, pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and others.
What Is The Macrophage Marker Market Size and Share 2026?
The macrophage marker market size has grown rapidly in recent years. It will grow from $0.52 billion in 2025 to $0.59 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing demand for macrophage profiling in immunology research, rising prevalence of cancer and inflammatory diseases, growing use of macrophage markers in drug discovery, increasing adoption of flow cytometry and immunohistochemistry, expanding research into macrophage polarization.What Is The Macrophage Marker Market Growth Forecast?
The macrophage marker market size is expected to see rapid growth in the next few years. It will grow to $0.94 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for precision macrophage phenotyping, rising adoption of multiplex biomarker analysis, growing demand for macrophage-based therapeutic development, increasing use of macrophage markers in companion diagnostics, expanding applications in personalized medicine. Major trends in the forecast period include increasing adoption of multiplex macrophage phenotyping, rising demand for highly specific macrophage biomarkers, growing use of macrophage markers in immuno-oncology research, increasing preference for quantitative macrophage profiling, rising demand for standardized macrophage marker panels.Tariff Impact On Macrophage Marker Market
Tariffs are impacting the macrophage markers market by increasing the cost of imported antibodies, assay reagents, laboratory consumables, and specialized research equipment required for macrophage identification and characterization. This is increasing research and diagnostic costs and potentially slowing procurement, particularly in regions dependent on imported life-science products. Hardware- and reagent-intensive segments such as flow cytometry markers, immunohistochemistry markers, immunofluorescence markers, and enzyme-linked immunosorbent assay reagents are most affected due to global supply chain dependencies. However, tariffs are also encouraging local manufacturing, regional supplier diversification, and increased investment in domestic biotechnology and diagnostic ecosystems, creating long-term resilience in the market.
Global Macrophage Marker Market Segmentation
2) By Macrophage Phenotype: M1 Macrophage Markers, M2 Macrophage Markers 3) By Disease Area: Oncology And Infectious Diseases, Autoimmune Diseases, Cardiovascular Diseases, Neurological Disorders, Other Disease Areas 4) By Application: Research Use, Diagnostic Use And Drug Development 5) By End User: Research Institutes And Academic Centers, Pharmaceutical And Biotechnology Companies, Clinical And Diagnostic Laboratories, Other End Users Subsegments: 1) By Cluster of Differentiation 68: Tissue Macrophage Identification, Tumor-Associated Macrophage Identification, Macrophage Activation Assessment, Immunohistochemical Detection 2) By Cluster of Differentiation 163: Anti-Inflammatory Macrophage Profiling, Tissue-Resident Macrophage Characterization, Hemoglobin Scavenging Macrophage Assessment 3) By Cluster of Differentiation 206: M2 Macrophage Identification, Macrophage Polarization Assessment, Mannose Receptor Expression Analysis, Alternative Macrophage Activation Assessment 4) By Cluster of Differentiation 14: Monocyte And Macrophage Identification, Lipopolysaccharide Response Assessment, Innate Immune Activation Analysis, Monocyte-Derived Macrophage Characterization 5) By Cluster of Differentiation 11b: Myeloid Cell Identification, Integrin-Mediated Macrophage Characterization, Cell Adhesion Assessment, Phagocytic Activity Assessment 6) By Cluster of Differentiation 64: High-Affinity Immunoglobulin Receptor Analysis, Tissue Macrophage Characterization, Monocyte-Macrophage Differentiation Assessment, Interferon-Responsive Macrophage Profiling 7) By Cluster of Differentiation 11c: Dendritic Cell And Macrophage Characterization, Antigen-Presenting Cell Identification, Integrin Expression Analysis, Myeloid Cell Subset CharacterizationWhat Is The Driver Of The Macrophage Marker Market?
The rising prevalence of cancer worldwide is expected to propel growth of the macrophage marker market going forward. Cancer refers to a group of diseases in which abnormal cells grow uncontrollably, invade nearby tissues, and may spread to other parts of the body. The prevalence of cancer worldwide is increasing due to the aging global population, which is contributing to a higher number of cancer cases among older individuals. The rising prevalence of cancer is increasing the demand for macrophage markers by enabling the identification, characterization, and monitoring of tumor-associated macrophages within the tumor microenvironment. For instance, in July 2026, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, global cancer cases are projected to nearly double by 2050, reaching more than 35 million new cases annually. Therefore, the rising prevalence of cancer worldwide is driving growth of the macrophage marker industry.Key Players In The Global Macrophage Marker Market
Major companies operating in the macrophage marker market are Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Miltenyi Biotec B.V. & Co. KG, Bio-Techne Corporation, Cell Signaling Technology Inc., Bio X Cell LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., GeneTex Inc., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Creative Diagnostics, Abnova Corporation, Cusabio Technology LLC, Boster Biological Technology Co. Ltd., Biorbyt Ltd., Leinco Technologies Inc., Antibodies.com Ltd.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Macrophage Marker Market Trends and Insights
Major companies operating in the macrophage marker market are focusing on macrophage marker antibody development and product portfolio expansion, such as validated CD68 antibodies optimized for immunohistochemistry applications, to strengthen marker detection capabilities and support macrophage identification in translational and research applications. Validated CD68 antibodies refer to antibody-based reagents specifically developed and tested to detect CD68, a commonly used macrophage marker, in biological samples such as formalin-fixed paraffin-embedded (FFPE) tissue, enabling the identification and quantification of macrophages and tumor-associated macrophages. For instance, in June 2026, Boster Biological Technology, a China-based biotechnology company, expanded access to its validated CD68 antibody marker, a rabbit monoclonal antibody optimized for immunohistochemistry in human FFPE specimens. The antibody supports macrophage identification and tumor-associated macrophage quantification in translational research. This development aims to expand the availability of validated macrophage marker antibodies and support the growing use of macrophage characterization in biomedical research.What Are Latest Mergers And Acquisitions In The Macrophage Marker Market?
In June 2026, Agilent Technologies, Inc., a US-based company that develops and manufactures analytical instruments, acquired Biocare Medical, LLC, for $950 million. With this acquisition, Agilent aims to expand its pathology portfolio, strengthen its clinical and research pathology capabilities, accelerate innovation in cancer diagnostics, and enhance its ability to serve a broader global customer base across clinical and research settings. Biocare Medical, LLC is a US-based manufacturer of macrophage marker antibodies, particularly CD68 and CD163.
Regional Outlook/Insights
North America was the largest region in the macrophage marker market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Macrophage Marker Market?
The macrophage markers market consists of sales of multiplex cytokine detection panels, ribonucleic acid (RNA) in situ hybridization (RNA-ISH) probe kits, fluorescent cell labeling dyes, macrophage cell isolation kits (magnetic bead-based), and protein standard and control materials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Macrophage Marker Market Report 2026?
The macrophage marker market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the macrophage marker industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Macrophage Marker Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.59 billion |
| Revenue Forecast In 2030 | $0.94 billion |
| Growth Rate | CAGR of 12.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Marker Type, Macrophage Phenotype, Disease Area, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |